Remodeling of the Purkinje Network in Congestive Heart Failure in the Rabbit.


Journal

Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 1 7 2021
medline: 15 12 2021
entrez: 30 6 2021
Statut: ppublish

Résumé

Purkinje fibers (PFs) control timing of ventricular conduction and play a key role in arrhythmogenesis in heart failure (HF) patients. We investigated the effects of HF on PFs. Echocardiography, electrocardiography, micro-computed tomography, quantitative polymerase chain reaction, immunohistochemistry, volume electron microscopy, and sharp microelectrode electrophysiology were used. Congestive HF was induced in rabbits by left ventricular volume- and pressure-overload producing left ventricular hypertrophy, diminished fractional shortening and ejection fraction, and increased left ventricular dimensions. HF baseline QRS and corrected QT interval were prolonged by 17% and 21% (mean±SEMs: 303±6 ms HF, 249±11 ms control; n=8/7; Severe volume- followed by pressure-overload causes rapidly progressing HF with extensive remodeling of PFs. The PF network is central to both arrhythmogenesis and contractile dysfunction and the pathological remodeling may increase the risk of fatal arrhythmias in HF patients.

Sections du résumé

BACKGROUND
Purkinje fibers (PFs) control timing of ventricular conduction and play a key role in arrhythmogenesis in heart failure (HF) patients. We investigated the effects of HF on PFs.
METHODS
Echocardiography, electrocardiography, micro-computed tomography, quantitative polymerase chain reaction, immunohistochemistry, volume electron microscopy, and sharp microelectrode electrophysiology were used.
RESULTS
Congestive HF was induced in rabbits by left ventricular volume- and pressure-overload producing left ventricular hypertrophy, diminished fractional shortening and ejection fraction, and increased left ventricular dimensions. HF baseline QRS and corrected QT interval were prolonged by 17% and 21% (mean±SEMs: 303±6 ms HF, 249±11 ms control; n=8/7;
CONCLUSIONS
Severe volume- followed by pressure-overload causes rapidly progressing HF with extensive remodeling of PFs. The PF network is central to both arrhythmogenesis and contractile dysfunction and the pathological remodeling may increase the risk of fatal arrhythmias in HF patients.

Identifiants

pubmed: 34190577
doi: 10.1161/CIRCHEARTFAILURE.120.007505
pmc: PMC8288482
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007505

Subventions

Organisme : British Heart Foundation
ID : RG/11/18/29257
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/16/31330
Pays : United Kingdom

Références

Nat Commun. 2019 Jun 28;10(1):2889
pubmed: 31253831
J Mol Cell Cardiol. 2017 Mar;104:31-42
pubmed: 28111173
Sci Rep. 2019 Aug 13;9(1):11781
pubmed: 31409881
Circ Res. 2009 Jun 19;104(12):1382-9
pubmed: 19461043
Front Pediatr. 2013 Oct 28;1:33
pubmed: 24400279
Glob Heart. 2013 Mar 1;8(1):77-82
pubmed: 23998000
Circ Res. 2006 Dec 8;99(12):1384-93
pubmed: 17082478
Circ Arrhythm Electrophysiol. 2009 Jun;2(3):305-15
pubmed: 19808481
J Card Fail. 2010 Apr;16(4):320-6
pubmed: 20350699
Europace. 2010 Feb;12(2):254-60
pubmed: 20019013
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:34-7
pubmed: 26736194
IEEE Trans Med Imaging. 2013 Jan;32(1):8-17
pubmed: 22829390
Drug Discov Today Dis Models. 2008 Fall;5(3):185-193
pubmed: 32288771
Card Fail Rev. 2017 Apr;3(1):7-11
pubmed: 28785469
Pharmacol Ther. 2014 Mar;141(3):235-49
pubmed: 24140081
J Cell Sci. 1993 Aug;105 ( Pt 4):985-91
pubmed: 8227219
J Am Coll Cardiol. 2018 Dec 18;72(24):3112-3122
pubmed: 30545450
JACC Clin Electrophysiol. 2016 Apr;2(2):181-192
pubmed: 29766868
PLoS One. 2012;7(6):e40061
pubmed: 22768220
Heart Rhythm. 2009 Mar;6(3):370-7
pubmed: 19251214
J Physiol. 2007 Jul 15;582(Pt 2):675-93
pubmed: 17478540
J Mol Cell Cardiol. 2011 Nov;51(5):689-701
pubmed: 21741388
Circ Res. 2000 Mar 3;86(4):448-55
pubmed: 10700450
Front Physiol. 2016 Jun 02;7:197
pubmed: 27313537
Nat Rev Cardiol. 2016 Mar;13(3):155-66
pubmed: 26727298
Adv Exp Med Biol. 2012;740:1145-74
pubmed: 22453987
Circ Res. 1976 Aug;39(2):254-62
pubmed: 939011
Circulation. 2000 Jun 6;101(22):2631-8
pubmed: 10840016
Heart Rhythm. 2010 Jan;7(1):127-35
pubmed: 19939742
Pharmacol Ther. 2013 Aug;139(2):260-88
pubmed: 23612425
Heart Rhythm. 2009 Jul;6(7):1050-8
pubmed: 19481504
Circ Res. 1970 Mar;26(3):361-78
pubmed: 5415864
Circulation. 2010 Sep 28;122(13):1258-64
pubmed: 20837897
PLoS One. 2015 Oct 28;10(10):e0141452
pubmed: 26509807
J Clin Invest. 1969 Nov;48(11):2019-31
pubmed: 5398888
Circ Res. 2010 Feb 19;106(3):434-46
pubmed: 20167941
Am Heart J. 2002 Mar;143(3):398-405
pubmed: 11868043
Circulation. 2001 Oct 23;104(17):2095-100
pubmed: 11673352
Circulation. 2000 Jun 27;101(25):2975-80
pubmed: 10869272
Circulation. 2001 Mar 20;103(11):1591-8
pubmed: 11257090
PLoS One. 2012;7(4):e35299
pubmed: 22509404
J Physiol. 2007 Mar 1;579(Pt 2):465-71
pubmed: 17218348
JACC Heart Fail. 2016 May;4(5):345-7
pubmed: 27126282
Circulation. 2004 Aug 24;110(8):897-903
pubmed: 15302799
J Physiol. 1984 May;350:361-91
pubmed: 6086897
Pacing Clin Electrophysiol. 2018 Sep;41(9):1051-1059
pubmed: 30084120
N Engl J Med. 2002 Jun 13;346(24):1845-53
pubmed: 12063368
Korean Circ J. 2018 Dec;48(12):1081-1096
pubmed: 30403014
PLoS One. 2016 Oct 7;11(10):e0164093
pubmed: 27716829
Circ Res. 1971 Feb;28(2):136-47
pubmed: 4101066
Circ Res. 2009 May 8;104(9):1113-22
pubmed: 19359601
J Struct Biol. 1996 Jan-Feb;116(1):71-6
pubmed: 8742726

Auteurs

Sunil Jit R J Logantha (SJRJ)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.
Liverpool Centre for Cardiovascular Science and Department of Cardiovascular and Metabolic Medicine (S.J.R.J.L.), University of Liverpool, United Kingdom.

Xue J Cai (XJ)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

Joseph Yanni (J)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

Caroline B Jones (CB)

Alder Hey Children's National Health Service Foundation Trust, Liverpool, United Kingdom (C.B.J.).

Robert S Stephenson (RS)

School of Sport and Exercise Sciences, Liverpool John Moores University, United Kingdom (R.S.S., J.C.J.).
Institute of Clinical Sciences, University of Birmingham, United Kingdom (R.S.S.).

Luke Stuart (L)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.
Manchester University NHS Foundation Trust, United Kingdom (L.S.).

Gillian Quigley (G)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

Oliver Monfredi (O)

Division of Cardiovascular Medicine, University of Virginia, Charlottesville (O.M.).
Laboratory of Cardiovascular Medicine, National Institute on Aging, NIH Biomedical Research Center, Baltimore, MD (O.M.).

Shu Nakao (S)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.
Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kyoto, Japan (S.N.).

Il-Young Oh (IY)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.
Department of Internal Medicine, Seoul National University Bundang Hospital, Republic of Korea (I.-Y.O.).

Tobias Starborg (T)

Wellcome Centre for Cell Matrix Research (T.S.), University of Manchester, United Kingdom.

Ashraf Kitmitto (A)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

Akbar Vohra (A)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

Robert C Hutcheon (RC)

Division of Clinical Sciences (R.C.H.), University of Liverpool, United Kingdom.

Antonio F Corno (AF)

Memorial Hermann Children's Hospital, University of Texas Health, Houston (A.F.C.).

Jonathan C Jarvis (JC)

School of Sport and Exercise Sciences, Liverpool John Moores University, United Kingdom (R.S.S., J.C.J.).

Halina Dobrzynski (H)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.
Department of Anatomy, Jagiellonian University, Medical College, Cracow, Poland (H.D.).

Mark R Boyett (MR)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

George Hart (G)

Division of Cardiovascular Sciences (S.J.R.J.L., X.J.C., J.Y., L.S., G.Q., S.N., I.-Y.O., A.K., A.V., H.D., M.R.B., G.H.), University of Manchester, United Kingdom.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH